Ray Dalio's THC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 29,337 shares of Tenet Healthcare Corporation (THC) worth $5.83 M, representing 0.02% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in THC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 282,071 shares. Largest reduction occurred in Q1 2025, reducing 207,218 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Tenet Healthcare Corporation (THC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenet Healthcare Corporation (THC) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +16,473 | New Buy | 16,473 | $41.22 |
| Q4 2013 | +5,256 | Add 31.91% | 21,729 | $42.11 |
| Q1 2014 | +11,671 | Add 53.71% | 33,400 | $42.81 |
| Q2 2014 | -18,675 | Reduce 55.91% | 14,725 | $46.93 |
| Q3 2014 | -14,725 | Sold Out | 0 | $0.00 |
| Q3 2015 | +10,647 | New Buy | 10,647 | $36.91 |
| Q4 2015 | -10,647 | Sold Out | 0 | $0.00 |
| Q1 2018 | +38,658 | New Buy | 38,658 | $24.24 |
| Q2 2018 | -22,753 | Reduce 58.86% | 15,905 | $33.57 |
| Q3 2018 | -15,905 | Sold Out | 0 | $0.00 |
| Q4 2018 | +52,869 | New Buy | 52,869 | $17.14 |
| Q1 2019 | -52,869 | Sold Out | 0 | $0.00 |
| Q2 2021 | +12,224 | New Buy | 12,224 | $67.00 |
| Q3 2021 | +3,061 | Add 25.04% | 15,285 | $66.47 |
| Q4 2021 | -15,285 | Sold Out | 0 | $0.00 |
| Q3 2022 | +4,272 | New Buy | 4,272 | $51.50 |
| Q4 2022 | +29,189 | Add 683.26% | 33,461 | $48.79 |
| Q1 2023 | +25,008 | Add 74.74% | 58,469 | $59.42 |
| Q2 2023 | +7,551 | Add 12.91% | 66,020 | $81.38 |
| Q3 2023 | +15,857 | Add 24.02% | 81,877 | $65.89 |
| Q4 2023 | -5,533 | Reduce 6.76% | 76,344 | $75.57 |
| Q1 2024 | -10,449 | Reduce 13.69% | 65,895 | $105.11 |
| Q2 2024 | +30,742 | Add 46.65% | 96,637 | $133.03 |
| Q3 2024 | +28,486 | Add 29.48% | 125,123 | $166.20 |
| Q4 2024 | +282,071 | Add 225.43% | 407,194 | $126.23 |
| Q1 2025 | -207,218 | Reduce 50.89% | 199,976 | $134.50 |
| Q2 2025 | -112,813 | Reduce 56.41% | 87,163 | $176.00 |
| Q3 2025 | -57,173 | Reduce 65.59% | 29,990 | $203.04 |
| Q4 2025 | -653 | Reduce 2.18% | 29,337 | $198.72 |
Ray Dalio's Tenet Healthcare Corporation Investment FAQs
Ray Dalio first purchased Tenet Healthcare Corporation (THC) in Q3 2013, acquiring 16,473 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Tenet Healthcare Corporation (THC) for 29 quarters since Q3 2013.
Ray Dalio's largest addition to Tenet Healthcare Corporation (THC) was in Q4 2024, adding 407,194 shares worth $51.4 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 29,337 shares of Tenet Healthcare Corporation (THC), valued at approximately $5.83 M.
As of the Q4 2025 filing, Tenet Healthcare Corporation (THC) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Tenet Healthcare Corporation (THC) was 407,194 shares, as reported at the end of Q4 2024.